REXBURG, Idaho, July 18, 2025 /PRNewswire/ -- Activated Insights, the leading provider of experience management and training solutions for long-term and post-acute care organizations,...
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions
SAN FRANCISCO, July 16, 2025 /PRNewswire/ -- Piccolo Medical, Inc. (Piccolo), a leading innovator in vascular access technology, today announced it has received 510(k) clearance...
TOKYO, July 15, 2025 /PRNewswire/ -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a...
TOKYO, July 16, 2025 /PRNewswire/ -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a...
TOKYO, July 16, 2025 /PRNewswire/ -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a...
PALO ALTO, Calif., July 15, 2025 /PRNewswire/ -- Lucile Packard Children's Hospital Stanford, the cornerstone of Stanford Medicine Children's Health, is proud to announce...
Premier Program to Spotlight Health Leaders Driving Transformative Change in Digital Health
PHILADELPHIA, July 14, 2025 /PRNewswire/ -- As a leader in online health communities and...
SAN FRANCISCO, July 10, 2025 (GLOBE NEWSWIRE) -- Canopy, a leader in wearable safety and real-time location systems (RTLS) for healthcare, and Commure, the company behind next-generation AI infrastructure for health systems, today announced a strategic partnership to enhance support for Commure Strongline customers and ensure continued innovation in staff safety.